Latest Breaking News On - நீபீ - Page 3 : comparemela.com
Pengakuan Melly Goeslaw soal Penampilan yang Lebih Langsing
liputan6.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from liputan6.com Daily Mail and Mail on Sunday newspapers.
Ajaib, Melly Goeslaw Kurus Mendadak | Republika Online
republika.co.id - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from republika.co.id Daily Mail and Mail on Sunday newspapers.
Peptomyc ficha a un exdirectivo de Novartis como presidente del consejo
expansion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from expansion.com Daily Mail and Mail on Sunday newspapers.
KKR Appoints Giacomo Di Nepi as Senior Advisor for Private Equity in Europe LONDON (Business Wire) KKR, a leading global investment firm, today announced the appointment of Giacomo Di Nepi as a Senior Advisor, effective immediately. In his role, Mr. Di Nepi will advise KKR on Healthcare investment opportunities and support existing portfolio companies.
Mr. Di Nepi brings nearly 40 years of global experience in the Healthcare sector. He began his career at McKinsey, followed by 11 years at Novartis where he held a number of executive roles, including CEO of Novartis Italy and Global Head of the Infectious Diseases, Transplantation, and Immunology Business Unit and member of the Global Pharma Executive Committee. He also served as CEO of Takeda Europe. In 2009 he launched the European operations of Intermune near Basel, with the company growing exponentially under his leadership until a USD 8.3bn exit to Roche in 2015. He subsequently became CEO of Polyphor, a Swiss biopharma compa
(2)
Appointment further demonstrates focus on expanding the firm s presence in the Healthcare sector
KKR, a leading global investment firm, today announced the appointment of Giacomo Di Nepi as a Senior Advisor, effective immediately. In his role, Mr. Di Nepi will advise KKR on Healthcare investment opportunities and support existing portfolio companies.
Mr. Di Nepi brings nearly 40 years of global experience in the Healthcare sector. He began his career at McKinsey, followed by 11 years at Novartis where he held a number of executive roles, including CEO of Novartis Italy and Global Head of the Infectious Diseases, Transplantation, and Immunology Business Unit and member of the Global Pharma Executive Committee. He also served as CEO of Takeda Europe. In 2009 he launched the European operations of Intermune near Basel, with the company growing exponentially under his leadership until a USD 8.3bn exit to Roche in 2015. He subsequently became CEO of Polyphor, a Swiss biopharma com